-The Times of India CHENNAI: In a major step to make cancer cure affordable for patients and their families, the retail prices of several anti-cancer drugs, including commonly used chemotherapy injections for lung cancer treatment, have been slashed by up to 87% by the drug price control authority. After reviewing the data collected from drug manufacturers, the National Pharmaceutical Pricing Authority’s May 15 memorandum has brought nine anti-cancer drugs in its price...
More »SEARCH RESULT
Total Matching Records found : 283
Holes in cancer drug price cap -GS Mudur
-The Telegraph Call to govt to adopt 'cost-based' control The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices remain “prohibitive”, a network of patients’ rights groups said on Saturday. The All India Drug Action Network (Aidan) said the National Pharmaceutical Pricing Authority’s cap on profit margins in effect “legitimises” the...
More »With Health Ministry arms not on same page, who will give a helping hand to these Cancer patients? -Maitri Porecha
-The Hindu Business Line Govt’s Wellness Centres have identified over 37,000 patients, but can they be treated under Ayushman Bharat with their data not shared with NHA? The Union Health Ministry has identified thousands of new Cancer patients, but is unable to treat them. Reason: Its own departments are not coordinating among themselves, and the patients are left high and dry. On February 21, the Ministry released startling statistics that it had identified...
More »NPPA caps trade margins of 42 cancer drugs at 30% -Sushmi Dey
-The Times of India NEW DELHI: The government has capped trade margins of 42 cancer drugs at 30% expanding the span of price control to curtail undue profiteering by chemists and drug stockists on various medicines which were so far outside price regulation. The move is expected to bring major relief to around 1.5 million Cancer patients in India reeling under exponentially high treatment cost leading to heavy out-of-pocket expenditure. In a detailed...
More »Indu Bhushan -- CEO of Pradhan Mantri Jan Arogya Yojana (PM-JAY) -- interviewed by Bindu Shajan Perappadan (The Hindu)
-The Hindu The CEO of the Pradhan Mantri Jan Arogya Yojana on the challenges and scope of the scheme and responses from the States Indu Bhushan is the CEO of the world’s largest government-funded health insurance scheme, the Pradhan Mantri Jan Arogya Yojana (PM-JAY), which was launched by Prime Minister Narendra Modi on September 23. Until his appointment as CEO of PM-JAY, Mr. Bhushan served as director general for the East Asia...
More »
